Natco Pharma Ltd

Natco Pharma is engaged in the business of pharmaceuticals which comprises research and development, manufacturing and selling of bulk drugs and finished dosage formulations.

Pros:
Company is virtually debt free.
Company has good consistent profit growth of 54.36% over 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 27.15%
Company has been maintaining a healthy dividend payout of 19.98%
Cons:
Promoter's stake has decreased

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019
325 460 670 565 428 427 562 768 539 544 557 456
248 356 410 324 291 305 276 384 321 323 348 307
Operating Profit 77 105 260 241 137 122 286 383 218 220 208 148
OPM % 24% 23% 39% 43% 32% 29% 51% 50% 40% 41% 37% 33%
Other Income 5 3 6 -1 3 6 11 20 36 40 23 31
Interest 3 4 5 6 4 4 4 3 3 5 6 5
Depreciation 13 14 14 14 15 16 17 18 18 20 21 22
Profit before tax 66 90 248 221 121 107 276 382 232 235 205 152
Tax % 28% 26% 21% 20% 23% 21% 21% 22% 22% 23% 22% 21%
Net Profit 48 66 195 177 94 85 218 300 182 182 160 121
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 TTM
251 335 444 457 460 524 661 739 825 1,042 2,020 2,185 2,094
210 274 363 366 364 414 512 560 615 777 1,337 1,256 1,300
Operating Profit 41 61 81 91 96 109 149 179 210 266 683 928 795
OPM % 16% 18% 18% 20% 21% 21% 23% 24% 25% 25% 34% 42% 38%
Other Income 15 14 5 5 -1 9 2 17 0 12 14 40 130
Interest 7 10 15 15 14 23 26 37 32 23 18 15 19
Depreciation 8 9 14 20 16 16 22 30 47 51 54 66 81
Profit before tax 41 56 57 62 65 80 102 129 132 204 624 887 825
Tax % 23% 26% 20% 22% 20% 26% 36% 24% 1% 24% 22% 22%
Net Profit 30 41 44 49 54 60 72 103 135 157 486 696 644
EPS in Rs 2.17 2.85 3.09 3.39 3.73 3.73 4.45 6.04 7.90 9.03 27.85 37.73
Dividend Payout % 11% 9% 8% 12% 11% 16% 17% 16% 12% 14% 24% 22%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:20.61%
5 Years:27.03%
3 Years:38.34%
TTM:-4.13%
Compounded Profit Growth
10 Years:32.63%
5 Years:54.36%
3 Years:67.85%
TTM:-7.44%
Return on Equity
10 Years:23.10%
5 Years:24.99%
3 Years:27.15%
Last Year:29.16%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
28 28 28 28 28 31 31 33 33 35 35 37 36
Reserves 153 190 230 278 324 442 502 693 813 1,261 1,614 3,035 3,452
Borrowings 76 94 126 120 220 259 338 240 312 113 222 173 386
94 108 144 129 137 173 212 233 227 419 447 470 428
Total Liabilities 351 421 527 554 709 905 1,083 1,200 1,385 1,828 2,318 3,716 4,303
155 210 234 262 270 320 583 645 710 710 833 1,019 1,247
CWIP 20 18 47 40 76 164 106 124 129 212 336 480 638
Investments 2 0 34 61 63 63 2 2 2 22 32 76 149
174 192 212 192 300 359 392 429 545 884 1,117 2,141 2,270
Total Assets 351 421 527 554 709 905 1,083 1,200 1,385 1,828 2,318 3,716 4,303

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
45 48 61 75 37 65 61 144 93 112 346 464
-39 -60 -74 -61 -89 -125 -111 -108 -120 -176 -299 -1,116
-8 9 16 -34 77 63 26 -35 29 154 -48 651
Net Cash Flow -2 -3 3 -20 25 3 -24 0 2 90 -1 -2

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
ROCE % 19% 23% 21% 19% 17% 16% 17% 18% 17% 18% 39% 35%
Debtor Days 49 41 51 46 56 66 72 59 85 92 86 106
Inventory Turnover 5.15 5.59 5.97 5.79 5.12 4.93 5.15 4.52 4.11 3.61 5.72 5.55